About This Site

What Peptide Testimonials is — and isn't

The name of this site is easy to misread, so let's be direct about it. "Testimonials" here does not mean customer reviews of a product. Peptide Testimonials sells nothing, and there is no product to review. It refers instead to what people in research-use and patient communities report experiencing with a compound — set next to, and never confused with, what a peer-reviewed study actually measured.

This site covers four compounds — GHK-Cu, KPV, semaglutide, and tirzepatide, with semaglutide as the lead entry — that sit at very different points on the evidence spectrum: an approved drug with a massive trial record, a research chemical with no human trials at all, and two compounds in between. The organizing idea is simple: every page separates what the studies show from what people report, and neither is allowed to stand in for the other.

How it is compiled

Two principles govern everything on this site.

First, every research claim is anchored to a citable source. Peer-reviewed journal articles, clinical-trial publications, and clinical-reference chapters are collected, numbered, and listed with DOIs and PubMed links on the references page. A statement in the text with a bracketed number can be checked against its source; a statement without one is either a general description or, when it concerns anecdote, explicitly labeled as such.

Second, anecdote is never dressed up as data. Community-reported effects — benefits and side effects alike — are described plainly, sourced to where the pattern was observed, and marked anecdotal, not clinical evidence wherever they appear. Where a compound has essentially no genuine community record, as with KPV, this site says so rather than inventing one to fill a template.

What it is not

Peptide Testimonials is not a pharmacy, a clinic, a telehealth service, or a vendor of any kind. It sells nothing, sources nothing, and has no affiliate or referral relationship with any pharmaceutical company, supplier, or research-chemical seller. It does not employ clinicians, diagnose conditions, or recommend a dose, schedule, or route of administration for any person.

Semaglutide and tirzepatide are prescription medicines available only through a licensed provider. GHK-Cu is a legal topical cosmetic ingredient whose systemic or injectable use is unapproved and unstudied. KPV is a laboratory research chemical with no human trials and no approved use. Readers looking for clinical guidance should speak with a licensed healthcare provider. Editorial correspondence about a citation, a correction, or a recently published study can go to the contact page; this site cannot and will not respond to requests for medical advice.